Technical Analysis for RTRX - Retrophin, Inc.

Grade Last Price % Change Price Change
grade C 21.14 -1.17% -0.25
RTRX closed up 0.71 percent on Thursday, July 18, 2019, on 84 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Up
See historical RTRX trend table...

Date Alert Name Type % Chg
NR7 Range Contraction -1.17%
NR7 Range Contraction 0.38%
NR7-2 Range Contraction 0.38%
Upper Bollinger Band Walk Strength 0.38%
NR7 Range Contraction -0.38%
Upper Bollinger Band Walk Strength -0.38%
Upper Bollinger Band Touch Strength -0.38%
Upper Bollinger Band Walk Strength -1.90%
Above Upper BB Strength -1.90%
Upper Bollinger Band Touch Strength -1.90%

Older signals for RTRX ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Retrophin, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of orphan drugs for the treatment of rare and life-threatening diseases. The company develops treatments for Focal Segmental Glomerulosclerosis (FSGS), Pantothenate Kinase-Associated Neurodegeneration (PKAN), Duchenne Muscular Dystrophy and other catastrophic diseases. Its products include RE-021, a small molecule angiotensin receptor blocker and selective endothelin receptor antagonist for the treatment of FSGS; and RE-024, a drug that restores the disruption in the biochemical Coenzyme A pathway caused by the non-functioning PANK2 encoded enzyme. The company also develops RE-001, a recombinant fusion protein that substitutes the dystrophin that is lacking in DMD patients; and RE-003, an investigational agent for spinal muscular atrophy. The company was founded in 2011 and is based in New York, New York.
Medicine Biopharmaceutical Medical Genetics Kidney Diseases Muscular Dystrophy Spinal Muscular Atrophy Duchenne Muscular Dystrophy Genetic Genealogy Dystrophy Channelopathies
Is RTRX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 33.0
52 Week Low 17.53
Average Volume 423,350
200-Day Moving Average 22.1552
50-Day Moving Average 19.5278
20-Day Moving Average 20.6445
10-Day Moving Average 20.993
Average True Range 0.723
ADX 30.69
+DI 22.1486
-DI 10.9513
Chandelier Exit (Long, 3 ATRs ) 19.781
Chandelier Exit (Short, 3 ATRs ) 21.689
Upper Bollinger Band 21.7389
Lower Bollinger Band 19.5501
Percent B (%b) 0.84
BandWidth 10.60234
MACD Line 0.4674
MACD Signal Line 0.4237
MACD Histogram 0.0436
Fundamentals Value
Market Cap 821.06 Million
Num Shares 38.4 Million
EPS -1.84
Price-to-Earnings (P/E) Ratio -11.63
Price-to-Sales 6.36
Price-to-Book 3.08
PEG Ratio -1.05
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 21.97
Resistance 3 (R3) 21.91 21.66 21.87
Resistance 2 (R2) 21.66 21.51 21.69 21.84
Resistance 1 (R1) 21.53 21.42 21.59 21.58 21.81
Pivot Point 21.28 21.28 21.31 21.30 21.28
Support 1 (S1) 21.14 21.13 21.21 21.20 20.97
Support 2 (S2) 20.89 21.04 20.92 20.94
Support 3 (S3) 20.76 20.89 20.91
Support 4 (S4) 20.81